Generix Lifesciences Private Limited

Generix Lifesciences Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
CIN U24110DL2007PTC164689 Incorporated 13 June 2007 ROC Delhi HQ New Delhi, Delhi, India
Active Private Limited Company pharma MSME · Micro
Revenue · FY 2024
₹1.22 Cr
▲ 649% YoY
Net profit · FY 2024
₹71.58 Lakh
Net margin 58.6%
EBITDA · FY 2024
₹91.43 Lakh
EBITDA margin 74.8%
Authorised capital
₹5 Cr
Registered with MCA
Paid-up capital
₹4 Cr
Issued & subscribed
Open charges
₹8.9 Cr
Satisfied ₹13.48 Cr
Company age
19 yrs
Est. 2007
Employees · EPFO
4
Provident fund records

About Generix Lifesciences Private Limited

Data last updated:

Generix Lifesciences Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 13 June 2007 and has been in existence for over 19 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24110DL2007PTC164689. Its GSTIN is 27AACCG8752E1ZJ (Maharashtra). The company holds 7 GST registrations, of which 2 are active.

The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹4 Cr. It is led by directors Rekha Jha and Sandeep Jha.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Ground Floor 207 Shahpur Jat, New Delhi, Delhi, India – 110049.

As per the financials filed for FY 2024, the company reported a revenue of ₹1.22 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹71.58 Lakh (net margin 58.6%) and EBITDA of ₹91.43 Lakh (EBITDA margin 74.8%). Revenue has declined at a compounded annual rate (CAGR) of 53% over three years and 26% over five years.

The company has about 4 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: GenLife. As per MCA filings, the company has open charges of ₹8.9 Cr and satisfied charges of ₹13.48 Cr on record. Court records list 20 cases involving the company, including 20 filed against it; 1 case is pending. The company has 1 deal on record (1 secondary share transfer); the latest was in March 2018.

Generix Lifesciences Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-28-0007943). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website genlife.in.

Company details

CIN U24110DL2007PTC164689
Registration Number 164689
Incorporation Date 13 June 2007
ROC Delhi
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-UP-28-0007943

Recognitions & Rankings of Generix Lifesciences

MSME (Udyam registered) Ministry of MSME
Category
Micro (2023-24)
Udyam number
UDYAM-UP-28-0007943

Contact details

Generix Lifesciences Private Limited's registered office is in New Delhi, Delhi. Its website is genlife.in. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Website
  • Social Media
  • Registered Address
    Ground Floor 207 Shahpur Jat, New Delhi, Delhi, India – 110049
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Generix Lifesciences Private Limited, buy the company report.

Comprehensive company report
Generix Lifesciences Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Generix Lifesciences operates one associated brand: GenLife. Each brand links to its own profile.

BrandDescriptionWebsite
Provision of nutraceutical products and health tools to address nutritional and lifestyle-related health issues.genlife.in

Business activity

The main business activity of Generix Lifesciences is trade. In detail, this covers retail trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG2Retail Trading

To see the full business activity and turnover split of Generix Lifesciences Private Limited, buy the company report.

Financials of Generix Lifesciences Private Limited

FY 2025 filings available

Generix Lifesciences Private Limited reported revenue of ₹1.22 Cr (up 649% YoY) for FY 2024.

Revenue · FY 2024
₹1.22 Cr ▲ 649%
Net profit · FY 2024
₹71.58 Lakh margin 58.6%
EBITDA · FY 2024
₹91.43 Lakh margin 74.8%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 649%
3 years · compounded
▲ 53%
5 years · compounded
▼ 26%
EBITDA CAGR growth
1 year
▲ 225%
3 years · compounded
▲ 31%
5 years · compounded
▲ 22%

Revenue rose 649% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 26%. EBITDA rose 225% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹91.43 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹71.58 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin74.8%
Net Profit Margin58.6%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Generix Lifesciences Private Limited, buy the company report.

Board of directors of Generix Lifesciences Private Limited

Generix Lifesciences has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Rekha JhaDirector26 Nov 20205 Years 11 MonthsCurrent
Sandeep JhaDirector13 Jun 200719 Years 5 MonthsCurrent

Auditor

Generix Lifesciences Private Limited is audited by ANUJ GARG & COMPANY for the financial year 2023.

Auditor firmFinancial yearFirm registration number
ANUJ GARG & COMPANYFY 2023003473N

Shareholding

The shareholding of Generix Lifesciences Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Generix Lifesciences Private Limited, buy the company report.

Charges & borrowings

Open charges
₹8.9 Cr
Satisfied charges
₹13.48 Cr
Breakdown by lending institutions
Others₹9.95 Cr
Edelweiss Retail Finance Limited₹3.00 Cr
Kotak Mahindra Bank Limited₹0.53 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
25 Aug 2017100122192Others₹8.9 CrSatisfied
27 Jun 2016100043629Others₹1.05 CrSatisfied
29 Jan 201510551716Edelweiss Retail Finance Limited₹1.87 CrSatisfied
29 Nov 201410542465Edelweiss Retail Finance Limited₹1.13 CrSatisfied
28 Sep 201010240864Kotak Mahindra Bank Limited₹53 LakhSatisfied

To see the full charge records of Generix Lifesciences Private Limited, buy the company report.

Total charge records: 5 View all charges

Deals & funding

Generix Lifesciences Private Limited has 1 deal on record (1 secondary share transfer); the latest was in March 2018.

Total deals
1
Secondary share transfer
1

Deals on record (1 of 1)

WhenDealAmountParties
Mar 2018Secondary share transferUndisclosedBuyer: an individual
Seller: an individual

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Generix Lifesciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Generix Lifesciences Private Limited has a workforce of 4 employees on its EPFO records as of Aug 2020, across 1 active EPFO establishment.

Employee count
4
Active EPFO establishments
1
Employee growth
-50%

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2020-214
FY 2019-20
FY 2018-19
FY 2017-18
FY 2016-17

To see the full employee and EPFO history of Generix Lifesciences Private Limited, buy the company report.

GST

Generix Lifesciences has 7 GST registrations: 2 active and 5 cancelled or inactive.

Total GSTINs
7
Active
2
Cancelled / inactive
5
GSTINStateStatusRegistered on
27AACCG8752E1ZJMaharashtraActive01 Jul 2017
24AACCG8752E1ZPGujaratActive28 Mar 2018

To see the full GST registrations and return filing status of Generix Lifesciences Private Limited, buy the company report.

Recent activity

Generix Lifesciences Private Limited has 6 board changes on record since 2007: 2 appointments and 4 cessations. The latest: Rekha Jha ceased to be Additional Director on 31 Dec 2020.

AGM
Generix Lifesciences Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Generix Lifesciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi I.
Charges
A charge registered on 25 Aug 2017 via Charge ID 100122192 with Others was fully satisfied on 03 Jan 2025.
Charges
A charge with Others of Rs. 8.90 Cr registered on 25 Aug 2017 with Charge ID 100122192 was modified on 11 Feb 2021.
Ceased
Rekha Jha ceased to be Additional Director.
Appointed
Rekha Jha was appointed as Director.
Ceased
Vinod Nair ceased to be Director.
Charges
A charge registered on 27 Jun 2016 via Charge ID 100043629 with Others was fully satisfied on 06 Nov 2017.
Charges
A charge registered on 29 Jan 2015 via Charge ID 10551716 with Edelweiss Retail Finance Limited was fully satisfied on 14 Sep 2017.
Charges
A charge with Others amounted to Rs. 8.90 Cr with Charge ID 100122192 was registered on 25 Aug 2017.
Charges
A charge with Others amounted to Rs. 1.05 Cr with Charge ID 100043629 was registered on 27 Jun 2016.
Charges
A charge registered on 29 Nov 2014 via Charge ID 10542465 with Edelweiss Retail Finance Limited was fully satisfied on 17 Jun 2016.

9 earlier events are in the company report.

Frequently asked questions

Generix Lifesciences is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 13 June 2007 (19+ years old) and is registered under CIN U24110DL2007PTC164689.

Generix Lifesciences has 2 current directors:

The latest financial statements of Generix Lifesciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Generix Lifesciences is 27AACCG8752E1ZJ, registered in Maharashtra. The company has 7 GST registrations in all, of which 2 are active and 5 are cancelled or inactive. Other active GSTINs include 24AACCG8752E1ZP (Gujarat).

The CIN (Corporate Identification Number) of Generix Lifesciences is U24110DL2007PTC164689. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Generix Lifesciences has 20 court cases on record: 20 filed against it. 1 is pending. Most are in the district courts.

Generix Lifesciences was incorporated on 13 June 2007, making it 19+ years old. It is registered with the Registrar of Companies, Delhi.

Generix Lifesciences has 1 deal on record (1 secondary share transfer); the latest was in March 2018.

Rekha Jha ceased to be Additional Director on 31 Dec 2020. Rekha Jha was appointed as Director on 26 Nov 2020. Vinod Nair ceased to be Director on 26 Nov 2020. Generix Lifesciences has 6 board changes on record in total.

Yes, Generix Lifesciences is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-28-0007943).